Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophil extracellular traps in asthma: implications for pathogenesis and therapy
Kunlu Shen1,2, Mengyuan Zhang1,2, Ruiheng Zhao1,3
1National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, Chinese Academy of Medical Sciences, Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, 100029, Beijing, China.
Eosinophil extracellular traps (EETs) can protect against pathogens but may worsen allergic asthma when overproduced during chronic inflammation. This review explores the dual role of EETs in asthma development and progression.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- Asthma is a prevalent chronic airway inflammatory disease with substantial healthcare costs.
- Eosinophils are key immune cells involved in asthma's pathogenesis.
- Eosinophil extracellular traps (EETs) are released by eosinophils as part of the innate immune response.
Purpose of the Study:
- To review the critical role of eosinophil extracellular traps (EETs) in the context of asthma.
- To elucidate the mechanisms by which EETs contribute to airway inflammation and allergic asthma.
Main Methods:
- Literature review of studies investigating eosinophils and EETs in asthma.
- Analysis of the composition and function of EETs.
- Examination of the link between chronic inflammation, EET overproduction, and asthma exacerbation.
Main Results:
- EETs possess antimicrobial properties and can limit pathogen spread.
- Overproduction of EETs in chronic inflammatory conditions, such as asthma, can trigger and worsen allergic responses.
- EETs contribute to the inflammatory cascade in asthma.
Conclusions:
- Eosinophil extracellular traps (EETs) play a complex role in asthma, acting as both a protective mechanism and a contributor to disease exacerbation.
- Understanding the regulation and function of EETs is crucial for developing targeted asthma therapies.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

